Quick answers
- What is EndaCof DM?
- EndaCof DM is a brand name of Brompheniramine, dextromethorphan and phenylephrine, an over-the-counter medicine. The FDA NDC Directory lists 1 EndaCof DM product in 1 strength and form.
- Who makes EndaCof DM?
- Larken Laboratories, Inc. lists 1 of the 1 EndaCof DM products in the FDA NDC Directory.
- Is there a generic or store brand of EndaCof DM?
- Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a EndaCof DM product, 2 of them generic or store brands. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for EndaCof DM?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 1 EndaCof DM strength and form (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has EndaCof DM been recalled?
- No recall linked to EndaCof DM products (by their NDC code or label) appears in the FDA enforcement reports we use.
What EndaCof DM is
Each EndaCof DM product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Brompheniramine, dextromethorphan and phenylephrine · over-the-counter medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| brompheniramine maleate 1 mg/5 mL · dextromethorphan hydrobromide 5 mg/5 mL · phenylephrine hydrochloride 2.5 mg/5 mL liquid (oral) | EndaCof DM | 2 products, 2 companies | DailyMed |
Its page quotes the Drug Facts label and lists every brand and store brand: Brompheniramine, dextromethorphan and phenylephrine →
FDA approval
EndaCof DM products are sold under an FDA over-the-counter monograph: rules that set the allowed active ingredients, strengths and label wording, so these products do not need an individual FDA approval.
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| brompheniramine maleate 1 mg/5 mL · dextromethorphan hydrobromide 5 mg/5 mL · phenylephrine hydrochloride 2.5 mg/5 mL liquid | Generic: EndaCof DM | $0.0516 per mL Generic of the same strength and form: $0.0516–$0.0750 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list EndaCof DM
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of EndaCof DM products.
- Larken Laboratories, Inc.1 product
Recalls
No recall linked to EndaCof DM products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.